News

Deal Announcements

Bridge Laboratories Receives Expansion Round

Wednesday, January 16, 2008 5:37:00 AM PDT | VentureDeal Staff
GAITHERSBURG, MD -- Contract research organization (CRO) Bridge Laboratories announced that it has secured $18 million in series C venture capital financing.

Bridge is a preclinical CRO that provides US-regulatory compliant drug development services through its drug development lab and animal vivarium based in China.

No investor names were disclosed with the announcement.  The company intends to use the funding proceeds to expand its lab operations in China and expand sales and marketing in the United States.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1